Abstract
Patients with pacemakers or internal cardioverter-defibrillators (ICDs) are at risk for device malfunction or exposure to electromagnetic interference (EMI) from monopolar cautery, magnetic resonance imaging (MRI), radiofrequency ablation, electroconvulsive therapy, lithotripsy, and therapeutic radiation. The most common and potentially life-threatening adverse effects of EMI are inhibition of cardiac pacing (leading to bradycardia or asystole) and inadvertent shocks if an ICD interprets the EMI as a heart rate above the therapy trigger rate. Most experts recommend that a plan for device management for surgery be made by a qualified individual, and that the recommendation be based on knowledge of the proposed surgery and the information gleaned from a recent interrogation of the device. Technological advancement with subcutaneous ICDs and leadless pacemakers has demonstrated the need for continuous education for those taking care of implantable cardiac devices in perioperative period.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gold MR, Aasbo JD, El-Chami MF, Niebauer M, Herre J, Prutkin JM, Knight BP, Kutalek S, Hsu K, Weiss R, Bass E, Husby M, Stivland TM, Burke MC. Subcutaneous implantable cardioverter-defibrillator post-approval study: clinical characteristics and perioperative results. Heart Rhythm. 2017;14(10):1456–63.
Chang PM, Doshi R, Saxon LA. Subcutaneous implantable cardioverter-defibrillator. Circulation. 2014;129(23):e644–46.
Mickus GJ, Soliman GI, Reed RR, Martin AK. Perioperative management of a leadless pacemaker_ the paucity of evidence-based guidelines. J Cardiothorac Vasc Anesth. 2016;30(6):1594–8.
Crossley GH, Poole JE, Rozner MA, Asirvatham SJ, Cheng A, Chung MK, Ferguson Jr TB, Gallagher JD, Gold MR, Hoyt RH, Irefin S, Kusumoto FM, Moorman LP, Thompson A. The Heart Rhythm Society expert consensus statement on the perioperative management of patients with implantable defibrillators, pacemakers and arrhythmia monitors: facilities and patient management. Heart Rhythm. 2011;8:1114.
Allen M. Pacemakers and implantable cardioverter defibrillators. Anaesthesia. 2006;61:883–90.
Moses HW, Mullin JC. A practical guide to cardiac pacing. 6th ed. Philadelphia: Lippincott Williams & Wilkins; 2007. ISBN 978-0-7817-8881-6.
Bernstein AD, Daubert JC, Fletcher RD, et al. The revised NASPE/BPEG generic code for antibradycardia, adaptive-rate, and multisite pacing. Pacing Clin Electrophysiol. 2002;25:260–4.
Leung S-K, Lau C-P. Developments in sensor-driven pacing. Cardiol Clin. 2000;18:113–55.
Gallagher MD, David Hayes MD, Jane EH. ASA task force on perioperative management of patients with cardiac implantable electronic devices. Practice advisory for the perioperative management of patients with cardiac implantable electronic devices: pacemakers and implantable cardioverter-defibrillators. Anesthesiology. 2011;114:247–61.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Hall, M.L., Rooke, G.A. (2020). Implantable Cardiac Electronic Devices. In: Jackson, M., Huang, R., Kaplan, E., Mookherjee, S. (eds) The Perioperative Medicine Consult Handbook. Springer, Cham. https://doi.org/10.1007/978-3-030-19704-9_11
Download citation
DOI: https://doi.org/10.1007/978-3-030-19704-9_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-19703-2
Online ISBN: 978-3-030-19704-9
eBook Packages: MedicineMedicine (R0)